Molecular targets and compounds, and methods to identify the same, useful in the treatment of fibrosis

(canceled)

(canceled)

(canceled)

(canceled)

(canceled)

(canceled)

(canceled)

(canceled)

(canceled)

A method for treatment of a fibrotic condition in a mammal comprising administering to said mammal a pharmaceutical composition comprising an antibody or a fragment thereof which specifically binds to a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:

• 57-112, or comprising an agent selected from the group consisting of an antisense polynucleotide, a ribozyme, a small interfering RNA (siRNA), microRNA (miRNA) and a short-hairpin RNA (shRNA), wherein said agent comprises a nucleic acid sequence complementary to, or engineered from, a naturally-occurring polynucleotide sequence of about 17 to about 30 contiguous nucleotides of a nucleic acid sequence selected from the group consisting of SEQ ID NO:
• 1-56.

(canceled)

An in vitro method of inhibition of fibroblast migration and differentiation, comprising contacting a population of fibroblasts with an inhibitor of activity and/or expression of a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:

• 57-112